Trexquant Investment’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-74,424
| Closed | -$1.73M | – | 1538 |
|
|
2024
Q3 | $1.73M | Buy |
74,424
+21,015
| +39% | +$488K | 0.02% | 868 |
|
|
2024
Q2 | $1.3M | Buy |
+53,409
| New | +$1.3M | 0.02% | 912 |
|
|
2024
Q1 | – | Sell |
-10,956
| Closed | -$345K | – | 1419 |
|
|
2023
Q4 | $345K | Sell |
10,956
-40,915
| -79% | -$1.29M | 0.01% | 1210 |
|
|
2023
Q3 | $1.33M | Buy |
51,871
+17,230
| +50% | +$440K | 0.03% | 642 |
|
|
2023
Q2 | $994K | Buy |
+34,641
| New | +$994K | 0.03% | 762 |
|
|
2023
Q1 | – | Sell |
-21,284
| Closed | -$361K | – | 1424 |
|
|
2022
Q4 | $361K | Buy |
+21,284
| New | +$361K | 0.01% | 1040 |
|
|
2022
Q1 | – | Sell |
-5,939
| Closed | -$220K | – | 1330 |
|
|
2021
Q4 | $220K | Buy |
+5,939
| New | +$220K | 0.01% | 1100 |
|
|
2021
Q2 | – | Sell |
-5,428
| Closed | -$224K | – | 1076 |
|
|
2021
Q1 | $224K | Buy |
+5,428
| New | +$224K | 0.02% | 916 |
|
|
2020
Q2 | – | Sell |
-12,632
| Closed | -$172K | – | 1150 |
|
|
2020
Q1 | $172K | Buy |
+12,632
| New | +$172K | 0.01% | 997 |
|